Uteruslike masses of the ovary associated with breast cancer and raised serum CA 125.

OA: closed
Full text JSON View on PubMed View at publisher
AI-generated summary by qwen3.7-flash, 2026-09-10

Three cases of ovarian masses resembling the uterus, associated with breast cancer and elevated CA-125 levels, suggest an endomyometriosis etiology driven by metaplasia rather than congenital anomalies.

One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works

AI-generated deep summary by qwen3.7-flash, 2026-08-26 · read from full text

This case series describes three patients aged 38 to 43 who presented with uteruslike masses of the ovary, a rare condition where the ovarian tissue grossly and microscopically resembles uterine structures. Two of these individuals also had concurrent breast carcinomas and elevated serum CA-125 levels, which initially raised clinical suspicion for ovarian malignancy. The authors conclude that the presence of residual ovarian stroma in patients with breast cancer suggests metaplasia rather than a congenital anomaly as the underlying cause, noting that elevated CA-125 is consistent with the endomyometriosis nature of the lesion. Relevance to endometriosis: listed as one indication for GnRH antagonists, though the paper's main focus is uterine fibroids.

Read from the paper's body, not the abstract. Not a substitute for reading the paper. No clinical advice. How this works

Abstract

We describe three cases of a uteruslike mass of the ovary, a condition in which the ovary is replaced by a mass that grossly and microscopically resembles the uterus. The patients were 38, 43, and 39 years of age, and only the first was nulliparous. Two of them also had breast carcinomas. Two patients also had elevated CA 125 levels that gave rise to a clinical suspicion of ovarian malignancy. There were no anatomic abnormalities in any of the patients. The presence of residual ovarian stroma in two of the patients (both of whom had breast cancer) suggests that metaplasia rather than a congenital anomaly is the cause. Elevated CA 125 levels are consistent with the endomyometriosis nature of the lesion.
Full text 976 characters · extracted from oa-doi-fallback · click to expand
Original Articles Uteruslike Masses of the Ovary Associated With Breast Cancer and Raised Serum CA 125 - Sanjay A. Pai - Sangeeta B. Desai - Anita M. Borges American Journal of Surgical Pathology 22(3):p 333-337, March 1998. We describe three cases of a uteruslike mass of the ovary, a condition in which the ovary is replaced by a mass that grossly and microscopically resembles the uterus. The patients were 38, 43, and 39 years of age, and only the first was nulliparous. Two of them also had breast carcinomas. Two patients also had elevated CA 125 levels that gave rise to a clinical suspicion of ovarian malignancy. There were no anatomic abnormalities in any of the patients. The presence of residual ovarian stroma in two of the patients (both of whom had breast cancer) suggests that metaplasia rather than a congenital anomaly is the cause. Elevated CA 125 levels are consistent with the endomyometriosis nature of the lesion. Copyright © Lippincott-Raven Publishers

Text is read by the "Ask this paper" AI Q&A widget below. Extraction quality varies by source — PMC NXML preserves structure cleanly, OA-HTML may include some navigation residue, and OA-PDF can have broken hyphenation. The publisher copy (via DOI) is the canonical version.

My notes (saved in your browser only)

Ask this paper AI returns verbatim quotes from the full text · source: oa-doi-fallback

Answers must be backed by verbatim quotes from this paper's full text. Hallucinated quotes are dropped automatically; if no verbatim passage answers the question, we say so. How this works

Citation neighborhood (no data yet)

We don't have any in-corpus citations linked to this paper yet. The paper's references may be in our DB but unresolved to ``paper_id`` (resolution happens at ingest when the cited DOI matches a row we already have). Run the cross-source citation reconcile pass to retry.

Source provenance

europepmc
last seen: 2026-09-06T09:34:12.023084+00:00